Explore the words cloud of the Nano-OligoMed project. It provides you a very rough idea of what is the project "Nano-OligoMed" about.
The following table provides information about the project.
UNIVERSITE DE STRASBOURG
|Coordinator Country||France [FR]|
|Total cost||598˙500 €|
|EC max contribution||598˙500 € (100%)|
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
|Duration (year-month-day)||from 2017-12-01 to 2021-11-30|
Take a look of project's partnership.
|1||UNIVERSITE DE STRASBOURG||FR (STRASBOURG)||coordinator||180˙000.00|
|2||UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA||IT (ROMA)||participant||162˙000.00|
|3||UNIVERSITA DEGLI STUDI DI PARMA||IT (PARMA)||participant||130˙500.00|
|4||NANOMOL TECHNOLOGIES SL||ES (CERDANYOLA DEL VALLES)||participant||126˙000.00|
|5||ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING MCGILL UNIVERSITY||CA (MONTREAL)||partner||0.00|
|6||THE REGENTS OF THE UNIVERSITY OF CALIFORNIA||US (OAKLAND CA)||partner||0.00|
|7||UNIVERSIDAD DE LA HABANA||CU (PLAZA)||partner||0.00|
Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine. Towards the great challenges that nanotechnology arise, Nano-OligoMed has the ambition to establish and support a network of international collaboration, enabling a collaborative scientific team to effectively use a diversity of approaches and strategies to generate and test hybrid nanomaterials for the efficient and safe systemic delivery of oligonucleotide-based therapeutic agents. To this end, we have set-up a joint multidisciplinary scientific collaborative programme that through exchange, international mobility, and strongly collaborative transfer of knowledge and training activities between 4 European and 3 extra-European countries, will bring together leading experts under the field of “nanomaterials in biomedicine”. The scientific aim of Nano-OligoMed is the creation of degradable hybrid structures that combine the rigid, inert silica with the delicate programmable oligonucleotides or artificial oligonucleotide-mimics. The possibility to develop novel oligonucleotide-based materials will enable a) the degradation of the drug carrier at the presence of a specific input as a function of the intrinsic bio-responsive feature of oligonucleotides, b) the activation of a therapeutic function as a result of the bio-molecular interaction between the oligonucleotide-based material and the molecular target (i.e. miRNAs) and c) the delivery of the chemical payload (DNA and/or artificial mimics, even in combination with cancer drugs) upon cell internalization. The international academic networking, the broadening of the research skills, the educational activities, will provide to young (PhD students) and senior scientists, specific competences in the field of materials sciences, nanotechnology, molecular biology and molecular medicine.
|Protocols for the characterization of the behavior of hybrid supramolecular nanostructures||Other||2020-02-12 16:29:25|
|School on synthesis and characterization of hybrid materials for medical applications||Other||2020-02-07 12:44:16|
|Protocol for the study of stimuli-responsive DNA nanomachines||Other||2019-10-10 12:56:42|
|Porous silicon nanoparticles||Other||2019-10-10 12:56:28|
|Protocol for the synthesis of DNA, its modification and conjugation with FRET pair and small molecules||Other||2019-10-10 12:56:30|
|Project website||Websites, patent fillings, videos etc.||2019-10-10 12:56:29|
Take a look to the deliverables list in detail: detailed list of Nano-OligoMed deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANO-OLIGOMED" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "NANO-OLIGOMED" are provided by the European Opendata Portal: CORDIS opendata.